We are live on ! Find out more
MGNX icon

MacroGenics

124 hedge funds and large institutions have $188M invested in MacroGenics in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 47 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $835K

8.38% less ownership

Funds ownership: 97.27%88.89% (-8.4%)

16% less funds holding

Funds holding: 147124 (-23)

17% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 47

27% less capital invested

Capital invested by funds: $259M → $188M (-$71M)

63% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 35

Holders
124
Holders Change
-23
Holders Change %
-15.65%
% of All Funds
1.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
39
Reduced
47
Closed
35
Calls
$1.16M
Puts
$835K
Net Calls
+$322K
Net Calls Change
+$1.15M

MGNX Hedge Fund Activity: Q3 2024 in Review

124 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2024, worth a combined $188M — down 27% from $259M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of MGNX and 13 opened new positions — a net loss of 22 holders — while 47 trimmed existing stakes and 39 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.97M. The largest seller was RA Capital Management, exiting entirely with an estimated $8.85M sold.

  • 124 institutional investors held MacroGenics (MGNX) as of Q3 2024, down from 147 in Q2 2024.
  • Funds reported $188M of MacroGenics stock for Q3 2024, down 27% quarter-over-quarter.
  • 13 funds opened new MacroGenics positions in Q3 2024 and 35 closed out, a net change of -22 holders.
  • The largest MacroGenics buyer in Q3 2024 was Acadian Asset Management, an estimated $1.97M added.
  • The largest MacroGenics seller in Q3 2024 was RA Capital Management, an estimated $8.85M sold.

Based on aggregated 13F filings for Q3 2024.